Accuracy of serum neurofilament light to identify contrast-enhancing lesions in multiple sclerosis.

Gauruv BoseBrian C HealyChristian BarroVanessa F Moreira FerreiraShrishti SaxenaBonnie I GlanzHrishikesh A LokhandeMariann Polgar-TurcsanyiRohit BakshiHoward L WeinerTanuja Chitinis

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2023)

Spot sNfL >23.0 pg/mL or a 30.8% increase from remission provides modest prediction of CELs in patients <50 years; however, low sNfL does not obviate the need for MRI.

Keyphrases

multiple sclerosis
end stage renal disease
ejection fraction
newly diagnosed
magnetic resonance imaging
contrast enhanced
magnetic resonance
chronic kidney disease
peritoneal dialysis
prognostic factors
cerebrospinal fluid
white matter
disease activity
patient reported outcomes